Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study to Evaluate the Ocular Tolerance of SYL1001 in Healthy Volunteers

NCT01438281 is registered in ClinicalTrials.gov with Sylentis, S.A. as lead sponsor.

NCT NCT01438281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01438281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study to Evaluate the Ocular Tolerance of SYL1001 in Healthy Volunteers
Lead sponsor
Sylentis, S.A.
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2011
Completion date
June 30, 2012
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye, ocular pain